These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31336465)

  • 1. Factors associated with reluctance to initiate or continue oral antihyperglycemic agent (OAHA) treatments in type 2 diabetes mellitus patients in Japan: An observational patient-reported study.
    Kubo T; Okuyama K; Zhao X; Singh SS; Tokita S
    Diabetes Metab Syndr; 2019; 13(2):1201-1207. PubMed ID: 31336465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missed doses of oral antihyperglycemic medications in US adults with type 2 diabetes mellitus: prevalence and self-reported reasons.
    Vietri JT; Wlodarczyk CS; Lorenzo R; Rajpathak S
    Curr Med Res Opin; 2016 Sep; 32(9):1519-27. PubMed ID: 27144490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between depression and persistence with oral antihyperglycemic drugs in type 2 diabetes mellitus patients in Germany.
    Kostev K; Jacob L
    Psychiatry Res; 2018 Mar; 261():90-93. PubMed ID: 29291478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of illness perceptions and their associations with glycaemic control, medication adherence and chronic kidney disease in type 2 diabetes mellitus patients in Malaysia.
    Balasubramaniam S; Lim SL; Goh LH; Subramaniam S; Tangiisuran B
    Diabetes Metab Syndr; 2019; 13(4):2585-2591. PubMed ID: 31405680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure is associated with non-adherence to pharmacotherapy in elderly with type 2 diabetes mellitus in public health system Brazilians.
    Peres HA; Leira Pereira LR; Martinez EZ; Viana CM; Foss-Freitas MC
    Diabetes Metab Syndr; 2019; 13(2):939-946. PubMed ID: 31336548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional study clarifying profiles of patients with diabetes who discontinued pharmacotherapy: reasons and consequences.
    Tominaga Y; Morisky DE; Mochizuki M
    BMC Endocr Disord; 2021 Jun; 21(1):117. PubMed ID: 34120602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nepalese patients' anti-diabetic medication taking behaviour: an exploratory study.
    Sapkota S; Brien JE; Aslani P
    Ethn Health; 2018 Oct; 23(7):718-736. PubMed ID: 28277019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya.
    Aditama L; Athiyah U; Utami W; Rahem A
    J Basic Clin Physiol Pharmacol; 2020 Jan; 30(6):. PubMed ID: 31953995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adherence of type 2 diabetes patients on insulin analogues application: missed dose, time imprecision and dose reduction. The results of GAPP2TM(Global Attitudes of Physicians and Patient) survey in the Czech Republic].
    Prázný M
    Vnitr Lek; 2014 Nov; 60(11):999-1006. PubMed ID: 25600048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes.
    Iglay K; Cartier SE; Rosen VM; Zarotsky V; Rajpathak SN; Radican L; Tunceli K
    Curr Med Res Opin; 2015; 31(7):1283-96. PubMed ID: 26023805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.
    Mühlbacher A; Bethge S
    Eur J Health Econ; 2016 Dec; 17(9):1125-1140. PubMed ID: 26682548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon.
    Aminde LN; Tindong M; Ngwasiri CA; Aminde JA; Njim T; Fondong AA; Takah NF
    BMC Endocr Disord; 2019 Apr; 19(1):35. PubMed ID: 30943969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to initiation of oral antihyperglycemic and statin therapy in previously untreated patients with type 2 diabetes in the United States.
    Sun P; Tunceli K; Zhang Q; Seck T; Iglay K; Davies MJ; Ambegaonkar B; Radican L
    Curr Med Res Opin; 2013 Jul; 29(7):801-6. PubMed ID: 23621515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal insulin initiation use and experience among people with type 2 diabetes mellitus with different patterns of persistence: results from a multi-national survey.
    Perez-Nieves M; Ivanova JI; Hadjiyianni I; Zhao C; Cao D; Schmerold L; Kalirai S; King S; DeLozier AM; Birnbaum HG; Peyrot M
    Curr Med Res Opin; 2017 Oct; 33(10):1833-1842. PubMed ID: 28604111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence With Oral Antihyperglycemic Drugs in Type 2 Diabetes Mellitus Patients With Dementia in Germany.
    Jacob L; Adam-Schnepf L; Kostev K
    J Diabetes Sci Technol; 2018 Jan; 12(1):140-144. PubMed ID: 28681637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding medication adherence among patients of Turkish descent with type 2 diabetes: a qualitative study.
    Peeters B; Van Tongelen I; Duran Z; Yüksel G; Mehuys E; Willems S; Remon JP; Boussery K
    Ethn Health; 2015; 20(1):87-105. PubMed ID: 24588791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing barriers to medication adherence in underserved patients with diabetes in Texas.
    Bailey GR; Barner JC; Weems JK; Leckbee G; Solis R; Montemayor D; Pope ND
    Diabetes Educ; 2012; 38(2):271-9. PubMed ID: 22316643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and reliability of a self-reported measure of medication adherence in patients with Type 2 diabetes mellitus in Singapore.
    Wang Y; Lee J; Toh MP; Tang WE; Ko Y
    Diabet Med; 2012 Sep; 29(9):e338-44. PubMed ID: 22672497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and strategies for oral medication adherence among children and adolescents with Type 2 diabetes.
    Venditti EM; Tan K; Chang N; Laffel L; McGinley G; Miranda N; Tryggestad JB; Walders-Abramson N; Yasuda P; Delahanty L;
    Diabetes Res Clin Pract; 2018 May; 139():24-31. PubMed ID: 29427697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy and oral antidiabetic treatment for type 2 diabetes characterised by drug class and patient characteristics: A Japanese database analysis.
    Horii T; Iwasawa M; Kabeya Y; Atuda K
    Sci Rep; 2019 Sep; 9(1):12992. PubMed ID: 31506542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.